Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2007 1
2008 1
2009 1
2010 3
2011 8
2012 2
2013 8
2014 11
2015 9
2016 7
2017 10
2018 9
2019 9
2020 12
2021 14
2022 19
2023 10
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.
Kwatra SG, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Lynde C, De Bruin-Weller MS, Nahm WK, Sauder M, Gharib R, Barbarot S, Szepietowski JC, Conrad C, Fleischer A, Laquer VT, Misery L, Serra-Baldrich E, Lapeere H, Ahmad F, Jabbar Lopez ZK, Piketty C, Ständer S; OLYMPIA 2 Investigators. Kwatra SG, et al. N Engl J Med. 2023 Oct 26;389(17):1579-1589. doi: 10.1056/NEJMoa2301333. N Engl J Med. 2023. PMID: 37888917 Clinical Trial.
Biosimilars in Dermatology: Current Situation (Part II).
Puig L, Carretero G, Daudén E, Ferrándiz C, Marrón SE, Martorell A, Pérez-Suárez B, Rodriguez-Cerdeira C, Ruiz-Villaverde R, Sánchez-Carazo JL, Velasco M; en nombre del Grupo de Psoriasis de Academia Española de Dermatología y Venereología. Puig L, et al. Among authors: carretero g. Actas Dermosifiliogr. 2015 Sep;106(7):550-4. doi: 10.1016/j.ad.2015.04.008. Epub 2015 Jun 3. Actas Dermosifiliogr. 2015. PMID: 26049964 Free article. Review. English, Spanish.
Biosimilars in Dermatology: Current Situation (Part I).
Puig L, Carretero G, Daudén E, Ferrándiz C, Marrón SE, Martorell A, Pérez-Suárez B, Rodriguez-Cerdeira C, Ruiz-Villaverde R, Sánchez-Carazo JL, Velasco M; en nombre del Grupo de Psoriasis de Academia Española de Dermatología y Venereología. Puig L, et al. Among authors: carretero g. Actas Dermosifiliogr. 2015 Sep;106(7):545-9. doi: 10.1016/j.ad.2015.04.006. Epub 2015 May 16. Actas Dermosifiliogr. 2015. PMID: 25987472 Free article. Review. English, Spanish.
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis.
van Huizen AM, Menting SP, Gyulai R, Iversen L, van der Kraaij GE, Middelkamp-Hup MA, Warren RB, Spuls PI; SPIN MTX Consensus Survey Study Group; Schejtman AA, Egeberg A, Firooz A, Kumar AS, Oakley A, Foulkes A, Ramos AMC, Fougerousse AC, Carija A, Akman-Karakas A, Horváth B, Fábos B, Matlock BH, Claréus BW, Castro C, Ferrándiz C, Correa CC, Marchesi C, Goujon C, Gonzalez C, Maldonado-García C, Hong CH, Griffiths CEM, Vestergaard C, Echeverría CM, de la Cruz C, Conrad C, Törocsik D, Drvar DL, Balak D, Jullien D, Appelen D, Kim DH, de Jong EMGJ, El Gamal E, Laffitte E, Mahé E, Sonkoly E, Colombo EP, Vilarrasa E, Willaert F, Novoa FD, Handjani F, Valenzuela F, Vílchez-Márquez F, Gonzalez GO, Krisztián G, Damiani G, Krnjevic-Pezic G, Pellerano G, Carretero G, Hunter HJA, Riad H, Oon HH, Boonen HPJ, Moussa IO, García-Doval I, Csányi I, Brajac I, Turchin I, Grozdev I, Weinberg JM, Nicolopoulos J, Wells J, Lambert JLW, Ingram JR, Prinz JC, de Souza Sittart JA, Sanchez JL, Hsiao JP, Castro-Ayarza JR, Maul JT, van den Reek JMPA, Trcko K, Barber K, Reich K, Gebauer KA, Khobzei K, Maul LV, Massari LP, Fardet L, le Cleach L, Misery L, Chandrashekar L, Muresanu LI, Lecluse L, Skov L, F… See abstract for full author list ➔ van Huizen AM, et al. Among authors: carretero g. JAMA Dermatol. 2022 May 1;158(5):561-572. doi: 10.1001/jamadermatol.2022.0434. JAMA Dermatol. 2022. PMID: 35353175
[Guidelines on the use of methotrexate in psoriasis].
Carretero G, Puig L, Dehesa L, Carrascosa JM, Ribera M, Sánchez-Regaña M, Daudén E, Vidal D, Alsina M, Muñoz-Santos C, López-Estebaranz JL, Notario J, Ferrandiz C, Vanaclocha F, García-Bustinduy M, Taberner R, Belinchón I, Sánchez-Carazo J, Moreno JC; Grupo de Psoriasis de la AEDV. Carretero G, et al. Actas Dermosifiliogr. 2010 Sep;101(7):600-13. Actas Dermosifiliogr. 2010. PMID: 20858386 Spanish.
Redefining the therapeutic objective in psoriatic patients candidates for biological therapy.
Carretero G, Puig L, Carrascosa JM, Ferrándiz L, Ruiz-Villaverde R, de la Cueva P, Belinchon I, Vilarrasa E, Del Rio R, Sánchez-Carazo JL, López-Ferrer A, Peral F, Armesto S, Eiris N, Mitxelena J, Vilar-Alejo J, A Martin M, Soria C; from the Spanish Group of Psoriasis. Carretero G, et al. J Dermatolog Treat. 2018 Jun;29(4):334-346. doi: 10.1080/09546634.2017.1395794. Epub 2017 Nov 21. J Dermatolog Treat. 2018. PMID: 29099667 Review.
Lysine-PEGylated Cytochrome C with Enhanced Shelf-Life Stability.
Santos JHPM, Feitosa VA, Meneguetti GP, Carretero G, Coutinho JAP, Ventura SPM, Rangel-Yagui CO. Santos JHPM, et al. Among authors: carretero g. Biosensors (Basel). 2022 Feb 4;12(2):94. doi: 10.3390/bios12020094. Biosensors (Basel). 2022. PMID: 35200354 Free PMC article.
Violacein Targets the Cytoplasmic Membrane of Bacteria.
Cauz ACG, Carretero GPB, Saraiva GKV, Park P, Mortara L, Cuccovia IM, Brocchi M, Gueiros-Filho FJ. Cauz ACG, et al. Among authors: carretero gpb. ACS Infect Dis. 2019 Apr 12;5(4):539-549. doi: 10.1021/acsinfecdis.8b00245. Epub 2019 Feb 12. ACS Infect Dis. 2019. PMID: 30693760
110 results